Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1101 Madison St
Ste 1500
Seattle, WA 98104Phone+1 206-965-1700
Summary
- Dr. Chirag Shah is an obstetrician/gynecologist in Seattle, WA and is affiliated with multiple hospitals in the area, including Swedish Medical Center-First Hill, Swedish/Issaquah, EvergreenHealth, Overlake Medical Center, Providence Regional Medical Center Everett, and Valley Medical Center. He received his medical degree from Indiana University School of Medicine and has been in practice 15 years. He completed residency and fellowship at the University of Washington. He specializes in gynecologic oncology and is experienced in general gynecology, select urogynecologic procedures, gynecologic oncology, and robotic surgery.
Education & Training
- University of WashingtonFellowship, Gynecologic Oncology, 2006 - 2010
- University of WashingtonResidency, Obstetrics and Gynecology, 2002 - 2006
- Indiana University School of MedicineClass of 2002
Certifications & Licensure
- WA State Medical License 2006 - 2025
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery Start of enrollment: 2012 Feb 01
Publications & Presentations
PubMed
- 7 citationsBeyond enhanced recovery after surgery (ERAS): Evolving minimally invasive colectomy from multi-day admissions to same-day discharge.Michael M Vu, Karleigh R Curfman, Gabrielle E Blair, Chirag A Shah, Laila Rashidi
American Journal of Surgery. 2023-05-01 - 3 citationsTiming and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study.Talayeh S Ghezelayagh, Emily S Wu, Emma L Barber, Minh D Dao, Emese Zsiros
European Journal of Gynaecological Oncology. 2023-02-01 - 2 citationsReducing time to treatment and patient costs with breast cancer: the impact of patient visits.Sarah M.C. Sittenfeld, Zachary Greenberg, Zahraa Al-Hilli, Jame Abraham, Halle C. F. Moore
The Breast Journal. 2021-02-03
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: